has server used (United States) ping response time Hosted in Amazon Technologies Inc. Register Domain Names at CSC Corporate Domains, Inc.. This domain has been created 24 years, 119 days ago, remaining 246 days. You can check the 7 Websites and blacklist ip address on this server

Domain information

Registrar WHOIS Server:

Registrar URL:     See All 0+

Creation Date: 1997-04-08 24 years, 119 days

Updated Date: 2021-04-05 121 days ago

Expiry Date: 2022-04-09 246 days left     See All

  Sign up for notifications near expiration

Registrar: CSC Corporate Domains, Inc.

Abuse Email: [email protected]

Abuse Phone: 8887802723

  Full details

Top 10 Hosting Providers

Registrar URLDomain CountsRegistrar NameAbuse Email,280,, LLC[email protected]
www.tucows.com535,579Tucows Domains Inc.
networksolutions.com526,027Network Solutions, LLC[email protected]
www.namecheap.com333,839NameCheap, Inc.[email protected]
www.enom.com299,925eNom, LLC
www.publicdomainregistry.com294,948PDR Ltd. d/b/a[email protected],, LLC[email protected]
www.fastdomain.com161,753FastDomain Inc.[email protected]
www.ionos.com159,2071&1 IONOS SE[email protected]
www.networksolutions.com149,653Network Solutions, LLC[email protected]

Full view & Download

Keywords Suggestions

  › Sarepta therapeutics

  › Sarepta ir

  › Sarepta therapeutics stock

  › Sarepta buyout rumors

  › Sarepta

  › Sareptah

  › Sarepta tx

  › Sarepta therapy

  › Sarepta 10k

  › Sarepta ceo

  › Sarepta cfo

  › Sarepta crl

  › Sarepta def

  › Sarepta la

  › Sarepta ms

  › Sarepta nda

  › Sarepta oil

  › Sarepta pmo

  › Sarepta stock

  › Sarepta louisiana

See More:   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z  

› Sarepta therapeutics inc latest news

› Sarepta therapeutics news today

› Sarepta stock price

› Sarepta therapeutics news

› Sarepta therapeutics

› Sarepta stock

› Sarepta careers

› Sarepta dmd

Hosting Provider


Organization: Amazon Technologies Inc.     See All 439,891+

Provider URL:


IP Server: Reg: 2014-10-23, Updated: 2021-02-10

Blacklist: Check Backlist Status

Country: United States

Address: 410 Terry Ave N., Seattle, WA 98109, US

Latitude: 39.048100

Longitude: -77.472801

Name Server:


Abuse Email: [email protected]

Abuse Phone: +1-206-266-4064

Top 10 Hosting Providers

Website URLDomain CountsOrganizationAbuse Email
Google.com681,421Google LLC[email protected]
Godaddy.com650,, LLC[email protected]
Cloudflare.com637,900Cloudflare, Inc.[email protected]
Endurance.com488,827The Endurance International Group, Inc.[email protected]
Amazon.com439,891Amazon Technologies Inc.[email protected]
297,405Domain Name Services
Amazonaws.com287,121Amazon Technologies Inc.[email protected]
Liquidweb.com159,971Liquid Web, L.L.C[email protected]
Squarespace.com150,667Squarespace, Inc.[email protected]
Ripe.net128,362RIPE Network Coordination Centre[email protected]

Full view & Download

List of found email addresses

  1: [email protected]

  2: [email protected]

  3: [email protected]

  4: [email protected]

Find Websites hosted








At least 7 Sites on this server

Port Scanner (IP:

Contacts Sarepta Therapeutics, Inc.

  • Sarepta Therapeutics Headquarters 215 First Street Cambridge, MA 02142 [email protected] 617.274.4000   DA: 29 PA: 9 MOZ Rank: 38

Dr. Sarepta – Serenity Health

  • Get updates and the latest health news from Dr
  • Get Free Email Updates! Signup now and receive an email once I publish new content
  • I will never give away, trade or sell your email address
  • You can unsubscribe at any time
  • P: 404.937.7005 E: [email protected]   DA: 13 PA: 13 MOZ Rank: 27

Sarepta AFM Old Age Home Contacts Details

  • Sarepta AFM Old Age Home Contacts Details like Postal Address, Phone Number, Email, Website, and More are outlined below to help You reach them at ease
  • The Sarepta AFM Old Age Home [] contacts information responsible for getting in touch with the Institution can be found below as stated in the official   DA: 21 PA: 35 MOZ Rank: 58

Investor Relations Sarepta Therapeutics, Inc.

  • To receive automatic updates from Sarepta, please subscribe to our email alerts
  • Sarepta Therapeutics 2021 Corporate Presentation 4.9 MB
  • Morgan 2021 Presentation 2.5 MB
  • R&D Day 2018 Presentation 12.7 MB.   DA: 29 PA: 29 MOZ Rank: 61

FDA Emails Show How Upset Some Officials Were Over Sarepta

  • In a June 2 email to Woodcock and Dr
  • Richard Moscicki, an FDA deputy director, Shamim Ruff, a Sarepta senior vice president for regulatory affairs, wrote …   DA: 16 PA: 50 MOZ Rank: 70

Sarepta Nursing College Application Instruction 2022

  • Sarepta Nursing College Application Instruction 2022 for bachelor’s degree, diploma, higher certificate, postgraduate advanced diploma in nursing, and midwifery programs
  • An application must be made via the application forms (obtainable from the School Admission Office or download from the official website
  • Page Contents 1 Sarepta Nursing College Online Admission Application Instruction   DA: 21 PA: 49 MOZ Rank: 75

Sarepta And StrideBio Announce Multi-target Strategic

For a detailed description of risks and uncertainties Sarepta faces, you are encouraged to review Sarepta's 2018 Annual Report on Form 10-K and most recent Quarterly Report on Form 10-Q filed with the SEC as well as other SEC filings made by Sarepta.   DA: 29 PA: 50 MOZ Rank: 85

Nicole Yocum's Email & Phone Sarepta Therapeutics's

  • Nicole Yocum works as a Global Director, Clinical Operations at Sarepta Therapeutics, which is a Manufacturing company with an estimated 743 employees; and founded in 1980
  • They are part of the Clinical Operations team within the Medical & Health Department and their management level is Director.   DA: 16 PA: 31 MOZ Rank: 54

Sarepta Therapeutics To Commence Dosing Of The Next Study

  • -- Dosing with SRP-9001 commercial-process material to proceed following discussions with U.S
  • FDA ----Clinical dosing is expected to begin before the end of 2020 --CAMBRIDGE, Mass., Nov
  • 05, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced important updates related to the development …   DA: 29 PA: 50 MOZ Rank: 87

Rob Lowrance's Email & Phone Sarepta Therapeutics's

  • Rob Lowrance works as a Associate Director, Financial Planning & Analysis at Sarepta Therapeutics, which is a Manufacturing company with an estimated 743 employees; and founded in 1980
  • They are part of the Financial Planning & Analysis team within the Finance Department and their management level is …   DA: 16 PA: 31 MOZ Rank: 56

Sarepta Gene Therapy Misses Goal In Key Muscular Dystrophy

  • The trial of Sarepta's therapy, dubbed SRP-9001, was the first placebo-controlled study of an experimental muscular dystrophy gene therapy
  • The treatment is designed to work by replacing the faulty gene that causes Duchenne's, enabling patients' bodies to produce a modified version of the key muscle-building protein they lack, called dystrophin   DA: 21 PA: 50 MOZ Rank: 81

Sarepta, With New Data, Plans Final Push For Limb-girdle

  • Sarepta, with new data, plans final push for limb-girdle gene therapy
  • Sarepta Therapeutics on Monday added to a small, but growing, body of evidence that one of its experimental gene therapies might help treat a potentially deadly genetic disease called limb-girdle muscular dystrophy
  • The results aren't yet conclusive.   DA: 21 PA: 50 MOZ Rank: 82

Sarepta Therapeutics Announces Partnership With Roche In

– Roche obtains the exclusive right to launch and commercialize SRP-9001 outside the United States – – At closing, Sarepta will receive an upfront payment of $1.15 billion, comprising $750 million in cash and $400 million in Sarepta stock, priced at $158.59 per share of common stock – – Additionally, Sarepta is eligible to receive up to $1.7 billion in regulatory and sales milestones   DA: 29 PA: 50 MOZ Rank: 91

Sarepta Therapeutics To Announce Second Quarter 2021

  • CAMBRIDGE, Mass., July 28, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for …   DA: 21 PA: 50 MOZ Rank: 84

Sarepta, Continuing Its Gene Therapy Push, Helps Launch A

  • Sarepta Therapeutics, with help from a group of high-profile life sciences investors, has launched a startup focused on developing gene therapies for rare diseases
  • AavantiBio comes equipped with a $107 million Series A round from Perceptive Advisors, Bain Capital, RA Capital Management and Sarepta
  • Its president and CEO is Alexander "Bo" Cumbo   DA: 21 PA: 50 MOZ Rank: 85

Sarepta Therapeutics Announces Executive Management

  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, announced today its board of directors approved the appointments of several executive leadership positions: Ian Estepan to executive vice president and chief financial officer, Dallan Murray to senior vice president and chief commercial officer, and Louise Rodino-Klapac, Ph.D., to executive   DA: 12 PA: 50 MOZ Rank: 77

New Data Bolsters Sarepta Gene Therapies For Two Deadly

  • Sarepta Therapeutics is providing the latest evidence suggesting that two similar, experimental gene therapies it’s developing might help treat two deadly genetic diseases
  • As with previous updates to the two programs for Duchenne muscular dystrophy and a form of l imb-girdle muscular dystrophy , the results, presented at the Annual Congress   DA: 21 PA: 47 MOZ Rank: 84

Sarepta Therapeutics To Announce Second Quarter 2021

  • CAMBRIDGE, Mass., July 28, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report second quarter 2021 financial results after the Nasdaq Global Market closes on Wednesday, August 4, 2021
  • E.T., the Company will host a conference call to discuss its second quarter …   DA: 16 PA: 50 MOZ Rank: 83

Sarepta In $1.1 Billion Licensing Deal With Roche

Under its gene therapy licensing deal with Roche, Sarepta is eligible to receive up to $1.7 billion, in addition to the $1.1 billion, if the experimental treatment meets certain regulatory and   DA: 19 PA: 50 MOZ Rank: 87

Sarepta Therapeutics Provides Program Update For SRP-9001

  • 09, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has completed a Type C ‘written response only’ meeting with the Office of Tissues and Advanced Therapies (OTAT), part of the Center for Biologics Evaluation and Research (CBER) at the U.S   DA: 29 PA: 50 MOZ Rank: 98

Recently Analyzed

1: 1 seconds ago

2: 3 seconds ago

3: 3 seconds ago

4: 1 seconds ago

5: 1 seconds ago

6: 1 seconds ago

7: 4 seconds ago

8: 0 seconds ago

9: 0 seconds ago

10: 3 seconds ago

Tool Checker

Domain Expiry Date Updated

Expiry DateExpiry DateDomain ProviderHosting Provider
Vault.com2 years, 253 days, LLCAmazon Technologies Inc.
Linengineering.com4 years, 5 days leftNetwork Solutions, LLCAmazon Technologies Inc. 343 days leftFastDomain Inc.The Endurance International Group, Inc. 79 days, LLCUnified Layer
Aquafil.com1 year, 6 days leftEuroDNS S.A.Cloudflare, Inc. 116 days leftCSC Corporate Domains, Inc.FedEx 59 days leftNetwork Solutions, LLCIQVIA Holdings Inc
Paml.ca1 year, 146 days leftGo Daddy Domains Canada, IncGoogle LLC 74 days, LLCLinode 246 days leftCSC Corporate Domains, Inc.Amazon Technologies Inc.

<< See All >>

.COM - 10,595,200+   .ORG - 1,117,549+   .EDU - 123,500+   .NET - 792,945+   .GOV - 30,232+   .US - 84,439+   .CA - 122,904+   .DE - 220,061+   .UK - 272,390+   .IT - 108,882+   .AU - 152,812+   .CO - 51,739+   .BIZ - 59,081+   .IO - 32,494+   .NL - 99,647+   .SG - 19,713+   .INFO - 81,589+   .IE - 26,934+   .ME - 25,076+   .FR - 98,576+   .EU - 61,372+   .RU - 165,043+   .PH - 9,511+   .INT - 1,166+   .IN - 87,021+   .ES - 38,035+   .CZ - 71,869+   .VN - 48,920+   .TV - 14,250+   .SITE - 9,829+   .RO - 37,484+   .PL - 44,520+   .PK - 10,373+   .MOBI - 4,464+   .LK - 5,507+   .CN - 66,137+   .CH - 66,914+   .AT - 31,992+  

Email Address Search | IP Address Blacklist Check | Hosting Providers | Domain Providers | Website Error Checker

© 2018 All rights reserved. Email: [email protected]